CLINICAL_TRIALS
trial_result
· 2016-02-22
Clinical Trial Update: Mesenchymal Stem Cells Treat Liver Cirrhosis [Phase 1, Phase 2]
Summary
A Phase 1/Phase 2 trial of mesenchymal stem cells for liver cirrhosis is currently suspended.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yufang Shi | Conditions: Liver Cirrhosis | Phase 1, Phase 2 | Status: SUSPENDED